ATTN: We are committed to keeping our patients informed regarding the recent cybersecurity incident involving McKesson. At this time, we are continuing to monitor the situation closely and are working to obtain the most current information available. We will provide updates as we receive additional information from McKesson and learn more about any potential impact. Thank you for your patience and trust as we navigate this situation together. CLICK HERE for more information.

Healthcare Team & Locations

Ligeng Tian, MD, PhD

Accepting New Patients

Medical Oncology - Ligeng Tian, M.D., Ph.D.

Specialties

Medical Oncology
Hematology

Primary Location

Newport News (Port Warwick III)
1051 Loftis Boulevard, Suite 100
Newport News, VA 23606

Medical Oncology / Hematology:
(757) 873-9400

View Location Information

Secondary Location

Hampton (CarePlex)
3000 Coliseum Drive
Hampton, VA 23666

Medical Oncology / Hematology:
(757) 827-9400

View Location Information

Ligeng Tian, MD, PhD

Accepting New Patients

Medical School

Beijing Medical University, China

Residency

Long Island Jewish Medical Center of Albert Einstein College of Medicine | Internal Medicine

Fellowship

Yale Medical School | Hematology and Oncology

Additional Degrees

Weill School of Medical Sciences at Cornell University |
PhD Molecular Biology and Genetics

Board Certification

  • Internal Medicine
  • Hematology
  • Medical Oncology

Biography

Dr. Tian is board-certified in Hematology, Medical Oncology, and Internal Medicine. She earned her medical degree from Beijing Medical University in China and her Ph.D. in Molecular Biology and Genetics from the Weill Graduate School of Medical Sciences at Cornell University in New York. She completed her Internal Medicine residency at Long Island Jewish Medical Center of Albert Einstein College of Medicine and went on to complete a fellowship in Medical Oncology and Hematology at Yale Medical School in Connecticut.

During her time at Yale, Dr. Tian participated in several clinical research studies and medical education. Her studies showed that bone marrow findings correlate poorly with disease activity in hemophagocytic lymphohistiocytosis (HLH). She remains committed to advancing cancer care through evidence-based medicine and personalized treatment approaches.

Dr. Tian is a member of several professional organizations, including the American Society of Clinical Oncology (ASCO) and the American Society of Hematology (ASH). She has special clinical interests in thoracic cancers, breast cancer, and benign and malignant blood disorders. She is dedicated to building meaningful relationships with her patients and developing individualized treatment plans that address each person's unique needs and goals.

Outside of work, Dr. Tian enjoys spending time with her family and traveling. 

Article on ASCO Connection
 

Listen to our podcast featuring Dr. Ligeng Tian